Clinical Trial Update: Rosuvastatin in African Americans With Cerebrovascular Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rosuvastatin in African Americans with cerebrovascular disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Wayne State University | Conditions: Stroke, Transient Ischemic Attack | Phase 4 | Status: TERMINATED